Larimar Therapeutics (LRMR) Q3 2025 Earnings

Aug 14Confirmed
Q3 2024
Q4 2024
Q2 2025
Q3 2025
-0.48
-0.4
-0.32
-0.24

Details

Expected EPS
-0.480258
Actual EPS
-0.41
Surprise EPS
0.07
Surprise Percent
+14.63%

Description

⁨Larimar Therapeutics⁩ (⁦LRMR⁩) has reported earnings of ⁦-0.41⁩ per share for ⁦Q3 2025⁩.

0 Comments

Share your thoughts